SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-080781
Filing Date
2021-06-14
Accepted
2021-06-14 16:20:39
Documents
3
Period of Report
2021-06-09
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2119680d1_8k.htm 8-K 41666
2 EXHIBIT 99.1 tm2119680d1_ex99-1.htm EX-99.1 25390
3 GRAPHIC image_001.jpg GRAPHIC 15173
  Complete submission text file 0001104659-21-080781.txt   89417
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 211014831
SIC: 2834 Pharmaceutical Preparations